¥60–70 billion in capital investment over the four-year medium-term management plan
First written in FY2019. 11 of 14 entries say "Advanced", first in FY2020. Latest entry: 2026-05-12.
0 other companies' latest entry also says "Advanced".
- 2026-05-12AdvancedResults
「新規連結会社の株式並びに有形固定資産の取得の増加等により、250億94百万円支出が増加しております。」
新規連結会社の取得と有形固定資産取得により、投資活動の支出が前期から増加している。 - FY2026-H1AdvancedAnnual report
「Net cash used in investing activities during the six-month interim period was ¥33,123 million. Cash outflows increased by ¥24,193 million due to the acquisition of shares in newly consolidated companies and increased purchases of property, plant and equipment, among other factors.」
Cash used in investing activities increased by ¥24,193 million year on year due to the acquisition of newly consolidated companies and purchases of property, plant and equipment, indicating progress in executing growth investments. - FY2023-Q3RestatedAnnual report
「Net cash used in investing activities during the nine-month period ended the third quarter was ¥11,182 million. This was ¥1,700 million lower than in the same period of the previous year, due to lower capital investment and progress in asset sales.」
The company continues capital investment and asset sales, but no new milestones, such as project completions, are stated. - FY2023-Q1AdvancedAnnual report
「Net cash used in investing activities during the three-month period ended the first quarter was ¥2,846 million, mainly due to expenditures for construction of a second plant for the industrial chocolate business in Brazil and a new cream plant for the emulsified and fermented ingredients business in China.」
Regarding growth investments under the medium-term management plan, the company advanced construction of a second plant in Brazil and a new cream plant in China, with cash used in investing activities during the first quarter totaling ¥2,846 million. - FY2022AdvancedAnnual report
「Capital investment for the fiscal year totaled ¥17,286 million.」
The company continued capital investments including the new US plant, the new European soy-based processed ingredients plant, the second HARALD plant, capacity expansion in Zhaoqing, and the new Fuji Brandenburg plant, recording annual investment of ¥17,286 million. - FY2022-Q3AdvancedAnnual report
「Net cash used in investing activities during the nine-month period ended the third quarter was ¥12,883 million, mainly due to capital investments in the construction of a new site for the plant-based fats and oils business in the US and a new site in Germany for the functional ingredients business serving the European and US markets.」
The company continued construction of new sites in the US and Germany related to the medium-term management plan, with cash used in investing activities for the nine months ended the third quarter totaling ¥12,883 million. - FY2022-Q2AdvancedAnnual report
「Net cash used in investing activities during the six-month period ended the second quarter was ¥8,192 million, mainly due to capital investments in the construction of a new site for the plant-based fats and oils business in the US and a new site in Germany for the functional ingredients business serving the European and US markets.」
The company continued construction of new sites in the US and Germany as capital investments related to the medium-term management plan, spending ¥8,192 million in investing activities for the six months ended the second quarter. - FY2022-Q1RestatedAnnual report
「Net cash used in investing activities during the three-month period ended the first quarter was ¥4,517 million, mainly due to capital investments in the construction of new sites for the plant-based fats and oils business in the US and the functional ingredients business serving the European and US markets in Germany.」
The company continues capital investment related to the medium-term plan, including the plant-based fats and oils site in the US and the functional ingredients site in Germany. No new milestones, such as project completions, are stated. - FY2021AdvancedAnnual report
「Capital investment for the fiscal year totaled ¥20,824 million.」
The company disclosed annual capital investment of ¥20,824 million, including investments in the US fats and oils plant, the German functional ingredients site and the new Chiba soy-based processed ingredients plant. - FY2021-Q3AdvancedAnnual report
「Net cash used in investing activities during the nine-month period ended the third quarter was ¥10,885 million, mainly due to capital investments in the construction of a new site for the plant-based fats and oils business in the US, a new site in Germany for the functional ingredients business serving the European and US markets, and a new plant for soy-based processed ingredients in Japan.」
The company continued to invest in new sites in the US and Germany and a new soy-based processed ingredients plant in Japan under the medium-term management plan, with cash used in investing activities for the nine months ended the third quarter totaling ¥10,885 million. - FY2021-Q2AdvancedAnnual report
「Net cash used in investing activities during the six-month period ended the second quarter was ¥7,012 million, mainly due to capital investments in the construction of a new site for the plant-based fats and oils business in the US, a new site in Germany for the functional ingredients business serving the European and US markets, and a new plant for soy-based processed ingredients in Japan.」
The company continued to invest in new sites in the US and Germany and a new soy-based processed ingredients plant in Japan under the medium-term management plan, with ¥7,012 million spent in investing activities for the six months ended the second quarter. - FY2021-Q1AdvancedAnnual report
「Cash flow from investing activities during the cumulative first quarter of the current consolidated fiscal year amounted to an outflow of ¥4,826 million, mainly due to capital expenditures for constructing new sites for the plant-based oils and fats business in the United States and the functional ingredients business serving the European and U.S. markets in Germany, as well as investments in core systems to upgrade global management, a measure under the medium-term management plan.」
The company disclosed capital investment spending during the quarter under the medium-term management plan, including construction of new sites in the US and Germany and investment in core systems. - FY2020AdvancedAnnual report
「Capital investment for the fiscal year totaled ¥18,042 million.」
In connection with the four-year capital investment plan of ¥60–70 billion, the company invested ¥18,042 million during the year and advanced projects including the new New Orleans plant, the new Chiba soy protein plant and the new Fuji Brandenburg plant. - FY2019First statedAnnual report
「The company planned capital investment of ¥60–70 billion over the four-year period of the medium-term management plan “Towards a Further Leap 2020” and is selectively making investments that exceed its investment criteria, which emphasize the cost of capital.」
The company presented a plan to invest ¥60–70 billion in capital expenditures over the 4 years from fiscal 2017 through fiscal 2020, together with a selective investment policy that emphasizes the cost of capital.